Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk
about
Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidenceMicronutrients in Oncological InterventionNew concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkersMolecular cancer prevention: Current status and future directionsSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureNutrition, dietary interventions and prostate cancer: the latest evidenceJNCI and cancer preventionMetabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesCoenzyme Q10 and α-tocopherol reversed age-associated functional impairments in mice.Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.Health risk assessment of environmental selenium: Emerging evidence and challenges (Review)Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.Prostate cancer progression and mortality: a review of diet and lifestyle factorsComparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial.A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentSelenium and Human Health: Witnessing a Copernican Revolution?Selenium supplementation and prostate cancer mortalityMultilevel modeling and value of information in clinical trial decision support.Prevention of prostate cancer: outcomes of clinical trials and future opportunities.Selenium and chronic diseases: a nutritional genomics perspective.Is the inverse association between selenium and bladder cancer due to confounding by smoking?Serum tocopherol levels and vitamin E intake are associated with lung function in the normative aging study.A Perspective on Prostate Carcinogenesis and ChemopreventionStatus and Interrelationship of Zinc, Copper, Iron, Calcium and Selenium in Prostate CancerA Nutritional Approach to the Prevention of Cancer: from Assessment to Personalized InterventionPreventing aggressive prostate cancer with proven cardiovascular disease preventive methodsCancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and miceIntake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studiesLessons learned from cancer prevention studies with nutrients and non-nutritive dietary constituents.Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).Yeast as a model system to study metabolic impact of selenium compounds.Selenium action in neuro-oncology.Nutritional supplements in age-related macular degeneration.Reaction of low-molecular-mass organoselenium compounds (and their sulphur analogues) with inflammation-associated oxidants.Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
P2860
Q26745552-ECE11036-CE14-459E-96BF-A999E78FAA44Q26764839-9E16BDEC-0E9A-4A33-9417-05435BE356DCQ26774577-33FFEAA9-8F89-468A-9499-959C48A37E00Q26797207-E8E1FD5E-E120-430D-807F-1C3A03676C1CQ28071946-FB458EB1-3D4B-4616-B8B2-7BE9EC634DB2Q28084566-0C7AAD03-2FC8-4D74-8F7D-ADFEC0CADCC0Q28389384-AD3FE223-ECF3-46BB-AEC4-1EF70B21B6A8Q30234898-BA48877B-1CB3-4EB4-99D4-AF474DA25648Q30401821-A117F378-63E0-48FE-8E6A-82A1EDED217CQ31001228-9B49F022-0B18-4096-8451-EAE250AA347DQ31112967-4D5B6948-B942-4C53-9A82-1BC25A748DD0Q33671643-8426B049-4882-4B88-A559-C83D30A53E4FQ33688644-BC4EB396-6CDC-4C35-BF63-4514E15047D6Q33802558-AFF3AC20-2BA4-4D04-9857-B66ABA659304Q34016998-620C8688-27CD-4BA9-A90D-C4A7155BB960Q34135313-04B71919-3F31-44CF-8CC6-5F7F27808B9FQ34411758-6D85EA75-F80B-40DA-A1CD-EC9B5B3D6E63Q34480665-E099202C-31CF-45AC-820C-BE2E1E8D13BAQ34974869-8F05DF2A-A3FC-4879-A87D-374B7D5DB33AQ35006548-93612AF8-277A-4147-B2EE-129D4836ED4CQ35067699-02A8A197-CD85-4A56-AA51-A44C0ACA9AC4Q35658168-7811B7C7-93B8-4D11-9E2A-6153E4F06CAAQ35661856-81B13F6A-584E-4026-BF34-31F3A0CC239FQ35929130-95C6F998-D1DD-47B3-9407-679CF426DA92Q36116269-19D2F1F7-B2C2-4AB8-AEE3-061DCF9EEA62Q36515783-21FE04CD-8BCD-46CD-BFB5-429336F178E4Q36738485-966CB987-8D6A-4EDD-A32F-C33FFD984EF2Q36748541-EE403FCE-A8C7-45A6-B642-771ED10F8494Q36769227-D599AAF8-1326-41E4-8BE0-5A3AFB9FED26Q36786996-99039798-BBA5-4012-932B-76B4B5BD9A99Q37002973-58D69A8A-50C6-4A1E-BFC8-C52CC7DC3962Q37067798-F3DADFA5-DEDC-41E8-B1DA-1504453F08BDQ37354516-5F37497B-0ED2-479F-AB51-3A22DCDCCD76Q37379368-C2A616D9-85D0-4645-B409-1F0E0063C7D5Q37603181-1041EFD5-8069-44C9-9948-12254A0D6C3BQ37698339-04EFD43B-8593-440F-9CA2-9BFF25949DAFQ38243994-CCB0A07D-D28E-48FC-AE2D-72489F8B668FQ38317289-B0CB2171-94DC-496B-980B-94F45CA514FBQ38411959-B8BFEA4F-1AB7-48ED-9604-C8F84D05F1CDQ38543567-9A715E48-AFBD-4FAD-9FDF-2C44B316B59D
P2860
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Baseline selenium status and e ...... tation on prostate cancer risk
@en
Baseline selenium status and e ...... ation on prostate cancer risk.
@nl
type
label
Baseline selenium status and e ...... tation on prostate cancer risk
@en
Baseline selenium status and e ...... ation on prostate cancer risk.
@nl
prefLabel
Baseline selenium status and e ...... tation on prostate cancer risk
@en
Baseline selenium status and e ...... ation on prostate cancer risk.
@nl
P2093
P2860
P356
P1476
Baseline selenium status and e ...... tation on prostate cancer risk
@en
P2093
Catherine M Tangen
Eric A Klein
Frank L Meyskens
Gary E Goodman
Howard L Parnes
Ian M Thompson
J Steven Morris
Lori M Minasian
Phyllis J Goodman
Scott M Lippman
P2860
P304
P356
10.1093/JNCI/DJT456
P407
P577
2014-02-22T00:00:00Z